Tsuyoshi Kudo

Hiroshima City Hiroshima Citizens Hospital

7-33 Motomachi, Naka-Ku

Hiroshima 730-8518

Japan

  • Hiroshima City Hiroshima Citizens Hospital

SCHOLARLY PAPERS

1

DOWNLOADS

35

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

A Phase Ii Study of Accelerated Hyperfractionated Thoracic Radiotherapy with Dose Escalation to 54 Gy Concurrently with Cisplatin and Etoposide for Limited-Stage Small-Cell Lung Cancer: Long-Term Results at a Single Institution

Number of pages: 38 Posted: 21 May 2024
Kanji Matsuura, Ritsuko Komaki, Miho Kono, Ayaka Ono, Tsubasa Kameoka, Tsuyoshi Kudo, Ikumi Shintani, Hayate Kusaba, Atsushi Kawakubo, Yasiharu Ando, Kiyoto Nishihara, Yasuo Iwamoto, Hiroyasu Shoda, Tsuyoshi Katsuta and Masayuki Kagemoto
Hiroshima City Hiroshima Citizens Hospital, affiliation not provided to SSRN, Hiroshima City Hiroshima Citizens Hospital, Hiroshima City Hiroshima Citizens Hospital, Hiroshima City Hiroshima Citizens Hospital, Hiroshima City Hiroshima Citizens Hospital, Hiroshima City Hiroshima Citizens Hospital, Hiroshima City Hiroshima Citizens Hospital, Hiroshima City Hiroshima Citizens Hospital, Hiroshima City Hiroshima Citizens Hospital, Hiroshima City Hiroshima Citizens Hospital, Hiroshima City Hiroshima Citizens Hospital, Hiroshima City Hiroshima Citizens Hospital, Hiroshima University and Hiroshima City Hiroshima Citizens Hospital
Downloads 35 (1,001,455)

Abstract:

Loading...

limited-stage small-cell lung cancer, LS-SCLC, accelerated hyperfractionated thoracic radiotherapy, Dose Escalation